DNA Degradation: Mechanisms, Inhibitors and Environmental Effects

Hydrolytic depurination removes a purine base from its sugar, leaving an abasic site. Such sites can block copying or contribute to subsequent strand cleavage. Other processes modify bases or directly break the backbone. One dominant pathway cannot be assumed for every environmental specimen.

Oxidation can produce lesions such as 8-oxoguanine, which can mispair during copying. Other lesions can block polymerase progression. Their effects depend on the enzyme and context; a potential sequence miscoding event is not automatically an extra length peak in an STR electropherogram.

Ultraviolet exposure can produce pyrimidine photoproducts, including connections between adjacent bases on the same strand. Formalin and other conditions can produce crosslinks affecting extraction or copying. These lesions should not all be described as uniform backbone fragmentation.

Endogenous and microbial nucleases can cleave DNA, with different substrate preferences and conditions. They do not all cut both strands simultaneously or act at one predictable rate. Tissue protection, drying and preservation can alter the outcome without guaranteeing intact targets.

As fragments become shorter, fewer molecules may span longer amplicons. A size-dependent reduction in recovery can be consistent with degradation, while inhibition and low template can overlap. An average length or visible decomposition stage does not uniquely predict the profile.

Temperature, moisture, pH, light, microbes and substrate chemistry interact with the starting material. Fixed daily survival deadlines and a universal twofold rate increase per ten degrees are not reliable case predictions. Germicidal UV exposure is also not equivalent to sunlight at a scene.

Bone mineral and dental structures can protect some targets, but do not completely exclude water or microbes. A tooth’s pulp is not always lost first, and root cementum can contain useful nucleated material. Protected soft tissue may also be informative.

Contact material contains variable cellular and extracellular sources. Counting one hundred recovered skin-like cells does not supply a fixed DNA mass, and porous surfaces do not always degrade contact DNA faster than every smooth surface. The actual history and recovery method matter.

Preservation should limit further change under specimen-specific procedures. A dry garment and liquid blood do not share one packaging or freezing rule. Record treatment and storage history as context, without inferring a precise lesion type solely from it.

Haem-related material, humic substances, melanin, some dyes, salts and other co-extracted compounds can interfere with genetic assays. Mechanisms include effects on polymerase activity, nucleic-acid interactions, reaction chemistry and fluorescence. A named compound need not act through one exclusive mechanism.

Research demonstrates that humic substances can suppress some fluorescent detection systems as well as amplification. A low signal is therefore not always proportional to less product. The effect depends on detection chemistry and concentration; findings from one dye system should not be assumed for every probe assay.

An internal amplification control can reveal inhibition affecting its own target under the assay conditions. A delayed or absent result prompts investigation, including control setup, reagent and instrument performance. It does not by itself prove which inhibitor is present or that every other cause has been excluded.

A normally amplifying control does not establish that the questioned sample contains no human DNA. Its target can differ in length, sequence or inhibitor sensitivity, and the case target can be low, damaged or outside the assay’s capability. Report the result within the method’s detection limits.

Extraction blanks, amplification negatives, positive controls and substrate comparisons answer different questions. ISO/IEC 17025 does not prescribe an identical synthetic internal control in every STR reaction worldwide. Use the applicable validated workflow and quality requirements rather than inventing a universal control design.

Organic extraction, silica or magnetic-bead methods and Chelex-based procedures offer different recovery and purification characteristics. The selection depends on specimen, amount, target length, throughput and validation. No method universally removes every inhibitor or retains all short DNA.

Organic extraction can separate DNA from proteins and other components, with risks of transfer loss or solvent carryover. It is not inherently incompatible with all automation or automatically the preferred method for every degraded bone. Silica-based procedures use controlled binding, washing and elution chemistry whose performance is buffer- and system-specific.

Chelex chelates metal ions and procedures can involve heating. Its extracts can support PCR-based STR work; single-stranded DNA is not categorically incompatible with STR amplification, which intentionally denatures templates. Avoid carrying resin or unsuitable chemistry into reactions, and recognise its purification limits.

Residual wash solvent, excess salt or other extraction reagents can themselves interfere with amplification. More washing is not always harmless and concentrating an eluate can concentrate inhibitors too. Use assessed modifications, controls and a clear record of losses or changes.

Differential sperm/non-sperm lysis is a fraction-enrichment method for suitable mixtures, not a universal inhibitor-removal method. Fractions can retain mixtures and carryover. Match the technique to the biological question rather than list it as an automatic step after every failed extraction.

Dilution can reduce inhibitor concentration while also reducing DNA entering the reaction. A tenfold dilution is not guaranteed to leave enough template, especially in trace work. Compare relevant controls and results under the method’s rules before interpreting an improvement or failure.

Additional purification, a suitable additive or a different polymerase–buffer system may help within a validated approach. Adding BSA or switching to a named enzyme is not a universal escalation recipe. A hot-start polymerase is not automatically an inhibitor-resistant forensic system.

Shorter amplification targets can improve recovery from some fragmented material because a shorter intact span is needed. Primer placement cannot make every allele equally short, and a kit covering many loci is not necessarily a miniSTR kit with all products below two hundred bases.

Mitochondrial sequencing, SNP work or other sequencing approaches can answer appropriate questions when sufficient suitable targets remain. Mitochondrial genome size should not be confused with the length of a particular nuclear or mitochondrial amplicon. Alternative methods have their own validation and interpretation requirements.

Sequencing is not immune to damage or inhibitors, and many preparation methods still rely on polymerase extension or amplification. It does not recreate lost DNA. Before consuming more material, consider whether another sample or a different supported question is the better option.

For blood, consider human target amount, haem-associated interference, substrate and treatment. Evaporation does not establish one fixed fortyfold haem concentration for every stain, and age alone does not predict inhibitory load. A weak profile should not be attributed to one cause without evidence.

For bone and teeth, assess preservation, sampling site and processing. Demineralisation and cleanup can help but may consume limited material and lose targets. A failed assay can justify investigation of another validated approach rather than a fixed nuclear-to-mitochondrial sequence.

For contact traces and mixtures, dropout, imbalance and artefacts affect donor evaluation. Probabilistic genotyping can model relevant features within its validated scope; it is not an extraction remedy or a guarantee of an informative result. State contributors, assumptions and propositions appropriately.

Retain raw data, controls, method versions, repeat attempts and the rationale for changes. Do not select only a successful-looking repeat while concealing discordant work. A partial result may remain informative, but its weight must come from the actual data and limitations.

Reporting requirements vary by jurisdiction. Teach the shared control-based reasoning and distinguish measured findings from explanations. A negative assay is not a statement that no biological material was ever present, and a compatible partial profile is not proof of an activity.